India, Feb. 18 -- Anbio Biotechnology said that it has priced its initial public offering of 1.60 million Class A ordinary shares at a public offering price of US$5.00 per Class A Ordinary Share. The Class A Ordinary Shares have been approved for listing on the Nasdaq Global Market and are expected to commence trading on February 19, 2025 under the ticker symbol NNNN.
The company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses. The Offering is expected to close on or about February 20, 2025.
The company plans to use proceeds from the Offering for expansion of sales and distribution network in the strategically selected markets, research and d...